Juan Sanchez | Vice President, Corporate Communications and Investor Relations |
Sharon Mates | Chairman and Chief Executive Officer |
Mark Neumann | Chief Commercial Officer |
Suresh Durgam | Chief Medical Officer |
Larry Hineline | Chief Financial Officer |
Jessica Fye | JP Morgan |
Charles Duncan | Cantor Fitzgerald |
Sumant Kulkarni | Canaccord |
Bo Chen | Evercore |
Roanna Ruiz | SVB Leerink |
Leo Timashev | RBC Capital Markets |
Roy Buchanan | JMP Securities |
Andrew Tsai | Jefferies |
Good morning, ladies and gentlemen, and welcome to the Intra-Cellular Therapies' Third Quarter Ended September 30, 2020 Financial Results Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's conference call is being recorded. I'd now like to turn the conference over to your host Dr.